Contact us

Thank you for your interest in Garg Law PLLC.

Our commitment to understanding your regulatory questions and business goals, and helping you achieve results starts here.

If you are looking for representation on a new matter, please fill out the form below to request a free consultation. The form enables us to conduct a preliminary check for potential conflicts of interest and to determine if we can proceed with the free consultation.

Miami FDA Cosmetic Facility Registration Attorney

This guide explains how cosmetic facility registration matters work for businesses in Miami — the rules, the deadlines, the process and the mistakes — and how Garg Law handles them. Miami is the principal port of entry for the southeastern United States — PortMiami and Miami International Airport together move a huge share of the country’s waterborne and air cargo, and the businesses that import, distribute and market FDA-regulated products across the Americas run their operations from here. More FDA-regulated freight crosses this city than almost any other American market.

Quick answer

Under MoCRA, cosmetic manufacturing facilities must register with FDA and renew biennially, products must be listed by a responsible person, and foreign facilities need a U.S. agent. It is the first registration regime American cosmetics has ever had — and imports from unregistered facilities are the first place it bites.

1. Overview: the regulatory framework

The Modernization of Cosmetics Regulation Act created cosmetics registration from a standing start: facilities that manufacture or process cosmetics for the U.S. market must register with FDA and renew every two years, and a responsible person — the entity on the label — must list each product with its ingredients and update listings on a defined cycle.

Foreign facilities register through a U.S. agent; contract-manufacturing relationships raise the recurring structural question of who registers and who lists when brand, formulator and filler are different companies. Small-business exemptions exist but are narrower than the industry assumed — and do not excuse products with higher-risk characteristics.

Enforcement flows through the border and the statute’s new powers: imports from facilities FDA cannot match to a registration invite holds and refusals, and MoCRA added suspension authority — a facility linked to serious adverse health consequences can have its registration suspended, stopping its products entirely. For Miami’s beauty import trade, registration status is now part of supplier due diligence.

2. What is at stake

The industry spent decades without registration obligations, which means legacy habits are now violations: unregistered contract fillers, unlisted product lines, foreign suppliers with no U.S. agent. Each surfaces at the least convenient point — the border, an inspection, an adverse-event inquiry — and each is cheap to fix before and costly after.

3. Step-by-step: how the matter proceeds

  1. Obligation mapping across brand, manufacturer and filler: who registers, who lists, who serves as responsible person
  2. Facility registrations and biennial renewals, with U.S. agent arrangements for foreign plants
  3. Product listing build-out — complete portfolios, correct ingredient declarations, update cycles calendared
  4. Supplier verification for importers: confirming upstream facilities actually registered before goods ship
  5. Issue response: registration-based holds, FDA information requests, and suspension-risk management

4. Common errors to avoid

  • Assuming MoCRA is someone else’s problem in a brand / formulator / filler chain — obligations attach at each layer
  • Importing from foreign facilities that never registered or named a U.S. agent
  • Listing launch products but never the line extensions and shade ranges that followed
  • Claiming the small-business exemption without checking its actual boundaries
  • Treating the biennial renewal as automatic — it is a filing, and lapsed is lapsed

Miami: the local picture

The work around Miami — international trade companies, food and beverage importers, cosmetics and consumer brands, medical and pharmaceutical distributors, logistics and freight networks — is FDA-regulated at nearly every turn, and matters here move on the gateway city — PortMiami, Miami International Airport and the headquarters of hemispheric trade. Garg Law's Miami office is at 1221 Brickell Avenue, and the practice was built for exactly this market: founder Shelly Garg spent years counseling importers at the world's largest dedicated international trade law firm before opening her own, and works at the crossroads of FDA and CBP compliance for foreign and domestic companies across the food, beverage, supplement, cosmetics, OTC drug and medical device industries.

Frequently asked questions

Which cosmetic companies must register with FDA?

Facilities that manufacture or process cosmetics for the U.S. market — domestic and foreign — must register and renew biennially. Brands that do not manufacture register nothing, but as responsible persons they must list products and stand behind safety substantiation and adverse-event obligations.

What is a responsible person under MoCRA?

The manufacturer, packer or distributor named on the product label — the entity that lists products with FDA, maintains safety substantiation, and receives and reports serious adverse events. For imported brands, identifying and equipping the responsible person is the structural first step.

Do foreign cosmetics factories need a U.S. agent?

Yes — foreign registered facilities designate a U.S. agent as FDA’s domestic contact. Importers should verify agent and registration status upstream; a supplier’s missing registration becomes the importer’s held shipment at MIA or PortMiami.

Are small cosmetics businesses exempt from registration?

MoCRA exempts qualifying small businesses from registration and listing — but the revenue thresholds are modest and the exemption excludes higher-risk product types. Many companies that assume exemption exceed the threshold or make an excluded product; the analysis is worth an hour before FDA makes it for you.

What happens if products ship from an unregistered facility?

The products risk being treated as violative at the border — holds, refusals — and the facility invites FDA attention including, in serious cases, the suspension authority MoCRA created. Registration status has become part of what entry screening and importer due diligence both check.

Related resources

Request a Consultation

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.
R.G. Client
I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.
Mike H. Client
Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.
Dr. Sastry Client
I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.
Claire P. Client

News & Insights

Get the latest news on FDA regulatory delivered straight to your inbox.